NCT06917131Recruiting
Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
The study aims to evaluate the effect of the royal jelly on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 34 (estimated)
- First submitted
- 1 Apr 2025
- Start date
- 18 Sept 2024
- Primary completion date
- 10 Dec 2026
- Lead sponsor
- Universidade Federal Fluminense
- Diseases
- High blood pressure
- NCT number
- NCT06917131
What you commit to
- Study type: Interventional
- Planned participants: 34
- From 18 Sept 2024 to the primary completion date, 10 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of catabolic drugs or antibiotics
Other illness
- Autoimmune diseases
- Infectious diseases
- Diabetes
- Chronic kidney disease
- Liver disease
- Cancer
- Allergy to bee stings
- Acute myocardial infarction (AMI)
- Stroke (CVA)
Other
- AIDS
- Pregnant women
- Use of antioxidant vitamin supplements, prebiotics, probiotics, or synbiotics
- Habitual intake of royal jelly
Who the study is looking for
- Diagnosis of stage 1 hypertension
- Regular treatment for more than 6 months
- No changes in medication doses during the last 3 months
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Denise mafra Coordinator of this site? Confirm its status | Rio de Janeiro | Brazil | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.